en Experimental Neurobiology

Cited by CrossRef (15)

  1. Xianjuan Kou, Shuangshuang Wu, Michael Kirberger, Ning Chen. Exercise, Autophagy and Chronic Diseases. .
    https://doi.org/10.1007/978-981-16-4525-9_8
  2. Zuzana Walker, Katherine L Possin, Bradley F Boeve, Dag Aarsland. Lewy body dementias. The Lancet 2015;386:1683
    https://doi.org/10.1016/S0140-6736(15)00462-6
  3. Eun-Jin Bae, Cheolsoon Lee, He-Jin Lee, Seokjoong Kim, Seung-Jae Lee. ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells. Exp Neurobiol 2014;23:365
    https://doi.org/10.5607/en.2014.23.4.365
  4. Rosa A. González-Polo, Rubén Gómez-Sánchez, Elisa Pizarro-Estrella, Sokhna M. S. Yakhine-Diop, Mario Rodríguez-Arribas, José M. Fuentes. Toxicity and Autophagy in Neurodegenerative Disorders. 2014.
    https://doi.org/10.1007/978-3-319-13939-5_6
  5. Sakshi Prasad, Maanya Rajasree Katta, Shuchi Abhishek, Rishala Sridhar, Sai Sudha Valisekka, Maha Hameed, Jasneet Kaur, Namrata Walia. Recent advances in Lewy body dementia: A comprehensive review. Disease-a-Month 2023;69:101441
    https://doi.org/10.1016/j.disamonth.2022.101441
  6. J. Schapansky, J. D. Nardozzi, F. Felizia, M. J. LaVoie. Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Human Molecular Genetics 2014;23:4201
    https://doi.org/10.1093/hmg/ddu138
  7. Werner J Geldenhuys, Samir M Abdelmagid, Patrick J Gallegos, Fayez F Safadi. Parkinson’s disease biomarker: a patent evaluation of WO2013153386. Expert Opinion on Therapeutic Patents 2014;24:947
    https://doi.org/10.1517/13543776.2014.931375
  8. Dan Hu, Jian-yi Niu, Jing Xiong, Shu-ke Nie, Fei Zeng, Zhao-hui Zhang. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson’s Disease. CURR MED SCI 2018;38:1012
    https://doi.org/10.1007/s11596-018-1977-z
  9. . Neural Dynamics of Neurological Disease. 2018.
    https://doi.org/10.1002/9781118634523.refs
  10. Jiangnan Ma, Jing Gao, Jing Wang, Anmu Xie. Prion-Like Mechanisms in Parkinson’s Disease. Front. Neurosci. 2019;13
    https://doi.org/10.3389/fnins.2019.00552
  11. Fanny M. Elahi, Bruce L. Miller. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 2017;13:457
    https://doi.org/10.1038/nrneurol.2017.96
  12. Paul Galatsis, Jaclyn L. Henderson, Bethany L. Kormos, Warren D. Hirst. Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease. 2017.
    https://doi.org/10.1007/7355_2014_69
  13. Devin Wahl, Samantha M. Solon-Biet, Victoria C. Cogger, Luigi Fontana, Stephen J. Simpson, David G. Le Couteur, Rosilene V. Ribeiro. Aging, lifestyle and dementia. Neurobiology of Disease 2019;130:104481
    https://doi.org/10.1016/j.nbd.2019.104481
  14. Zuzana Walker, Katherine L Possin, Bradley F Boeve, Dag Aarsland. Lewy Body Dementias. FOC 2017;15:85
    https://doi.org/10.1176/appi.focus.15105
  15. Karina S. Vitanova, Katie M. Stringer, Diana P. Benitez, Jonathan Brenton, Damian M. Cummings. Dementia associated with disorders of the basal ganglia. J of Neuroscience Research 2019;97:1728
    https://doi.org/10.1002/jnr.24508